Anti-Citrullinated Protein Antibodies

"Anti-Citrullinated Protein Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Autoantibodies to citrullinated-peptides and proteins.

Descriptor ID	D000075422
MeSH Number(s)	D12.776.124.486.485.114.323.095 D12.776.124.790.651.114.323.095 D12.776.377.715.548.114.323.095
Concept/Terms	Anti-Citrullinated Protein Antibodies Anti-Citrullinated Protein Antibodies Anti Citrullinated Protein Antibodies Antibodies, Anti-Citrullinated Protein Protein Antibodies, Anti-Citrullinated Citrullinated Protein Antibodies Antibodies, Citrullinated Protein Protein Antibodies, Citrullinated Anti-Citrullinated Peptide Antibodies Anti Citrullinated Peptide Antibodies Antibodies, Anti-Citrullinated Peptide Peptide Antibodies, Anti-Citrullinated Anti-Cyclic Citrullinated Protein Antibodies Anti-Cyclic Citrullinated Protein Antibodies Anti Cyclic Citrullinated Protein Antibodies Anti-CCP Anti CCP Cyclic Citrullinated Peptide Antibodies

Below are MeSH descriptors whose meaning is more general than "Anti-Citrullinated Protein Antibodies".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Immunoproteins [D12.776.124.486]
Immunoglobulins [D12.776.124.486.485]
Antibodies [D12.776.124.486.485.114]
Autoantibodies [D12.776.124.486.485.114.323]
Anti-Citrullinated Protein Antibodies [D12.776.124.486.485.114.323.095]
Serum Globulins [D12.776.124.790]
Immunoglobulins [D12.776.124.790.651]
Antibodies [D12.776.124.790.651.114]
Autoantibodies [D12.776.124.790.651.114.323]
Anti-Citrullinated Protein Antibodies [D12.776.124.790.651.114.323.095]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Immunoglobulins [D12.776.377.715.548]
Antibodies [D12.776.377.715.548.114]
Autoantibodies [D12.776.377.715.548.114.323]
Anti-Citrullinated Protein Antibodies [D12.776.377.715.548.114.323.095]

Below are MeSH descriptors whose meaning is related to "Anti-Citrullinated Protein Antibodies".

Below are MeSH descriptors whose meaning is more specific than "Anti-Citrullinated Protein Antibodies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-Citrullinated Protein Antibodies" by people in this website by year, and whether "Anti-Citrullinated Protein Antibodies" was a major or minor topic of these publications.

Bar chart showing 7 publications over 6 distinct years, with a maximum of 2 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2016	0	1	1
2017	1	0	1
2018	1	0	1
2019	2	0	2
2024	0	1	1
2026	1	0	1

Below are the most recent publications written about "Anti-Citrullinated Protein Antibodies" by people in Profiles.

Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess LJ, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Kristen Demoruelle M, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM. A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis. Arthritis Rheumatol. 2026 Apr; 78(4):809-820.

View in: PubMed
Aripova N, Kremer JM, Pappas DA, Reed G, England BR, Robinson BH, Curtis JR, Thiele GM, Mikuls TR. Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics. Rheumatology (Oxford). 2024 02 01; 63(2):542-550.

View in: PubMed
Harrold LR, Shan Y, Connolly SE, Alemao E, Rebello S, Guo L, Kremer JM. Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis. Curr Med Res Opin. 2020 02; 36(2):337-342.

View in: PubMed
Bergstra SA, Couto MC, Govind N, Chopra A, Salomon Escoto K, Murphy E, Huizinga TW, Allaart CF. Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry. RMD Open. 2019; 5(2):e000969.

View in: PubMed
Orange DE, Agius P, DiCarlo EF, Mirza SZ, Pannellini T, Szymonifka J, Jiang CS, Figgie MP, Frank MO, Robinson WH, Donlin LT, Rozo C, Gravallese EM, Bykerk VP, Goodman SM. Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Patients With Rheumatoid Arthritis in Clinical Remission. Arthritis Rheumatol. 2019 07; 71(7):1034-1041.

View in: PubMed
Baecklund E, Backlin C, R?nnelid J, Toes R, Huizinga T, ?hlin E, Askling J, Hochberg FH, Klareskog L, Kay J, Smedby KE. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis. Scand J Rheumatol. 2018 07; 47(4):270-275.

View in: PubMed
Harrold LR, Litman HJ, Connolly SE, Kelly S, Hua W, Alemao E, Rosenblatt L, Rebello S, Kremer JM. Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-a Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study. J Rheumatol. 2018 01; 45(1):32-39.

View in: PubMed
Chang HH, Liu GY, Dwivedi N, Sun B, Okamoto Y, Kinslow JD, Deane KD, Demoruelle MK, Norris JM, Thompson PR, Sparks JA, Rao DA, Karlson EW, Hung HC, Holers VM, Ho IC. A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22. JCI Insight. 2016 Oct 20; 1(17):e90045.

View in: PubMed

People

Explore

Similar Concepts

Top Journals